Armata Pharmaceuticals Files Q1 2025 10-Q

Ticker: ARMP · Form: 10-Q · Filed: May 14, 2025 · CIK: 921114

Armata Pharmaceuticals, INC. 10-Q Filing Summary
FieldDetail
CompanyArmata Pharmaceuticals, INC. (ARMP)
Form Type10-Q
Filed DateMay 14, 2025
Risk Levelmedium
Sentimentneutral

Sentiment: neutral

Topics: 10-Q, financials, pharmaceuticals

TL;DR

Armata Pharma's Q1 2025 10-Q is in. Check financials.

AI Summary

Armata Pharmaceuticals, Inc. filed its 10-Q for the period ending March 31, 2025. The filing details financial performance and operational updates for the first quarter of 2025. Key financial figures and disclosures related to its business operations are presented.

Why It Matters

This filing provides investors with a crucial update on Armata Pharmaceuticals' financial health and operational progress during the first quarter of 2025.

Risk Assessment

Risk Level: medium — As a pharmaceutical company, Armata is subject to inherent risks related to drug development, regulatory approvals, and market competition.

Key Numbers

Key Players & Entities

FAQ

What was Armata Pharmaceuticals' retained earnings as of March 31, 2025?

Armata Pharmaceuticals' retained earnings as of March 31, 2025, were not explicitly stated in the provided snippet, but the filing includes data points for retained earnings on various dates.

What is the company's SIC code?

The Standard Industrial Classification (SIC) code for Armata Pharmaceuticals, Inc. is 2836, which corresponds to Biological Products (No Diagnostic Substances).

When was Armata Pharmaceuticals formerly known as AmpliPhi Biosciences Corp?

Armata Pharmaceuticals was formerly known as AmpliPhi Biosciences Corp, with a date of name change on February 22, 2013.

What is the SEC file number for Armata Pharmaceuticals?

The SEC file number for Armata Pharmaceuticals is 001-37544.

What is the fiscal year end for Armata Pharmaceuticals?

The fiscal year end for Armata Pharmaceuticals is December 31.

Filing Details

This Form 10-Q (Form 10-Q) was filed with the SEC on May 14, 2025 regarding Armata Pharmaceuticals, Inc. (ARMP).

View full filing on EDGAR

View Full Filing

View this 10-Q filing on SEC EDGAR

View on Read The Filing